297 related articles for article (PubMed ID: 27377653)
1. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
[TBL] [Abstract][Full Text] [Related]
2. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
Guthrie GD; Eljamel S
J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
[TBL] [Abstract][Full Text] [Related]
3. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
4. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
Baftiu A; Johannessen Landmark C; Rusten IR; Feet SA; Johannessen SI; Larsson PG
Eur J Clin Pharmacol; 2016 Oct; 72(10):1245-1254. PubMed ID: 27411937
[TBL] [Abstract][Full Text] [Related]
5. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL
J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
8. Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database.
Nicholas JM; Ridsdale L; Richardson MP; Ashworth M; Gulliford MC
Seizure; 2012 Jul; 21(6):466-70. PubMed ID: 22608976
[TBL] [Abstract][Full Text] [Related]
9. Some common issues in the use of antiepileptic drugs.
Asconapé JJ
Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of epilepsy in glioblastomas.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
[TBL] [Abstract][Full Text] [Related]
11. Association between sociodemographic status and antiepileptic drug prescriptions in children with epilepsy.
Mattsson P; Tomson T; Edebol Eeg-Olofsson K; Brännström L; Ringbäck Weitoft G
Epilepsia; 2012 Dec; 53(12):2149-55. PubMed ID: 23061699
[TBL] [Abstract][Full Text] [Related]
12. Impact of reimbursement restrictions on the choice of antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
Boon P; Dejonghe P; Legros B; Sadzot B; van Rijckevorsel K; Schmedding E
Seizure; 2008 Jun; 17(4):350-7. PubMed ID: 18203628
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients.
Rigamonti A; Imbesi F; Silvani A; Gaviani P; Agostoni E; Porcu L; De Simone I; Torri V; Salmaggi A
J Neurol Sci; 2018 Jul; 390():14-19. PubMed ID: 29801876
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of epilepsy at presentation in glioblastoma patients.
Berendsen S; Varkila M; Kroonen J; Seute T; Snijders TJ; Kauw F; Spliet WG; Willems M; Poulet C; Broekman ML; Bours V; Robe PA
Neuro Oncol; 2016 May; 18(5):700-6. PubMed ID: 26420896
[TBL] [Abstract][Full Text] [Related]
15. Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.
Simó M; Velasco R; Graus F; Verger E; Gil M; Pineda E; Blasco J; Bruna J
J Neurooncol; 2012 Jul; 108(3):451-8. PubMed ID: 22407174
[TBL] [Abstract][Full Text] [Related]
16. Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study.
Larsson D; Åsberg S; Kumlien E; Zelano J
Seizure; 2019 Jan; 64():29-33. PubMed ID: 30529757
[TBL] [Abstract][Full Text] [Related]
17. Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients.
Pursche S; Schleyer E; von Bonin M; Ehninger G; Said SM; Prondzinsky R; Illmer T; Wang Y; Hosius C; Nikolova Z; Bornhäuser M; Dresemann G
Curr Clin Pharmacol; 2008 Sep; 3(3):198-203. PubMed ID: 18781906
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
[TBL] [Abstract][Full Text] [Related]
19. Optimizing antiepileptic drug treatment in tumoral epilepsy.
Perucca E
Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
[TBL] [Abstract][Full Text] [Related]
20. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.
Oberndorfer S; Piribauer M; Marosi C; Lahrmann H; Hitzenberger P; Grisold W
J Neurooncol; 2005 May; 72(3):255-60. PubMed ID: 15937649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
